Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
NCT05195112 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2023-02-23
Summary
The purpose of this study is to evaluate the Efficacy and Safety of MT921 in Subjects with Moderate to Severe Submental fat compared with Placebo.
Conditions
- Submental Fat
Interventions
- DRUG
-
MT921
Active ingredient
- DRUG
-
Normal Saline
Sponsors & Collaborators
-
Medy-Tox
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-24
- Primary Completion
- 2023-02-18
- Completion
- 2023-02-18
Countries
- South Korea
Study Locations
More Related Trials
-
A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat
NCT05154955 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)
NCT04897412 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of RZL-012 on Submental Fat Reduction
NCT04867434 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects.
NCT05466448 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of ZT002 Injection With Subjects With Overweight or Obesity
NCT07020884 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
NCT07142707 ·Status: RECRUITING ·Phase: PHASE1
-
A Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Efficacy of RZL-012 for Submental Fat Reduction in Healthy Volunteers.
NCT04086823 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL
NCT05164341 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of ZT002 Injection in Participants With Overweight or Obesity
NCT06371326 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of THR-4109 in Obese Subjects
NCT00485017 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects
NCT06350812 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase II Study of THDBH120 Injection in Overweight or Obese Subjects
NCT07036601 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability and Drug Levels of BMS-986172 in Healthy and Obese Participants, Including an Assessment of the Effects of Food on BMS-986172 Absorption
NCT04926051 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of S-309309 in Obese Adults
NCT05925114 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area
NCT01546142 ·Status: COMPLETED ·Phase: PHASE3
-
A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)
NCT00092859 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients
NCT05197556 ·Status: COMPLETED ·Phase: PHASE2
-
This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity
NCT06857617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants
NCT01749137 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM
NCT05199090 ·Status: TERMINATED ·Phase: PHASE2
-
To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese
NCT06396429 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat
NCT03982225 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label Study That Will Test a Second Treatment Session of RZL-012.
NCT05763160 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RM-493 Administered to Healthy, Obese, Non-diabetic Volunteers
NCT02431442 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients
NCT02041195 ·Status: COMPLETED ·Phase: PHASE1/PHASE2